Literature DB >> 22906741

Leptin promotes osteoblast differentiation and mineralization of primary cultures of vascular smooth muscle cells by inhibiting glycogen synthase kinase (GSK)-3β.

Melec G Zeadin1, Martin K Butcher, Stephen G Shaughnessy, Geoff H Werstuck.   

Abstract

In this study, we begin to investigate the underlying mechanism of leptin-induced vascular calcification. We found that treatment of cultured bovine aortic smooth muscle cells (BASMCs) with leptin (0.5-4 μg/ml) induced osteoblast differentiation in a dose-dependent manner. Furthermore, we found that leptin significantly increased the mRNA expression of osteopontin and bone sialoprotein, while down-regulating matrix gla protein (MGP) expression in BASMCs. Key factors implicated in osteoblast differentiation, including members of the Wnt signaling pathway, were examined. Exposure to leptin enhanced phosphorylation of GSK-3β on serine-9 thereby inhibiting activity and promoting the nuclear accumulation of β-catenin. Transfection of BASMCs with an adenovirus that expressed constitutively active GSK-3β (Ad-GSK-3β S9A) resulted in a >2-fold increase in GSK-3β activity and a significant decrease in leptin-induced alkaline phosphatase (ALP) activity. In addition, qRT-PCR analysis showed that GSK-3β activation resulted in a significant decrease in the expression of osteopontin and bone sialoprotein, but a marked increase in MGP mRNA expression. When taken together, our results suggest a mechanism by which leptin promotes osteoblast differentiation and vascular calcification in vivo.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22906741     DOI: 10.1016/j.bbrc.2012.08.011

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

Review 1.  The hunger games of skeletal metabolism.

Authors:  Natalie K Y Wee; Paul A Baldock
Journal:  Bonekey Rep       Date:  2014-11-12

Review 2.  Nonalcoholic fatty liver disease and decreased bone mineral density: is there a link?

Authors:  G Targher; A Lonardo; M Rossini
Journal:  J Endocrinol Invest       Date:  2015-05-24       Impact factor: 4.256

3.  Comparison of pro-inflammatory cytokines and bone metabolism mediators around titanium and zirconia dental implant abutments following a minimum of 6 months of clinical function.

Authors:  Christopher A Barwacz; Kim A Brogden; Clark M Stanford; Deborah V Dawson; Erica N Recker; Derek Blanchette
Journal:  Clin Oral Implants Res       Date:  2014-01-13       Impact factor: 5.977

4.  Adiponectin is a candidate biomarker of lower extremity bone density in men with chronic spinal cord injury.

Authors:  Ashley L Doherty; Ricardo A Battaglino; Jayne Donovan; David Gagnon; Antonio A Lazzari; Eric Garshick; Ross Zafonte; Leslie R Morse
Journal:  J Bone Miner Res       Date:  2014-01       Impact factor: 6.741

5.  Association Between Liver Fat and Bone Density is Confounded by General and Visceral Adiposity in a Community-Based Cohort.

Authors:  Belinda T Li; Tracey G Simon; Na Wang; Raymond T Chung; Kathleen E Corey; Laura E Dichtel; Elizabeth J Samelson; Douglas P Kiel; Michelle T Long
Journal:  Obesity (Silver Spring)       Date:  2021-02-02       Impact factor: 5.002

6.  The association of serum adiponectin with abdominal aortic calcification in Japanese male hemodialysis patients: a cross-sectional observational study.

Authors:  Takeshi Sakura; Senji Okuno; Eriko Nishio; Kyoko Norimine; Eiji Ishimura; Tomoyuki Yamakawa; Shigeichi Shoji; Masaaki Inaba
Journal:  Sci Rep       Date:  2017-07-25       Impact factor: 4.379

Review 7.  Novel insights into the relationship between nonalcoholic fatty liver disease and osteoporosis.

Authors:  Rafał Filip; Radosław P Radzki; Marek Bieńko
Journal:  Clin Interv Aging       Date:  2018-10-04       Impact factor: 4.458

Review 8.  Energy-Dense Diets and Mineral Metabolism in the Context of Chronic Kidney Disease⁻Metabolic Bone Disease (CKD-MBD).

Authors:  Mariano Rodriguez; Escolastico Aguilera-Tejero
Journal:  Nutrients       Date:  2018-12-01       Impact factor: 5.717

9.  Association Between Serum Leptin Level and Calcific Aortic Valve Disease.

Authors:  Yehong Liu; Yuying Gu; Ying Shen; Bowen Lin; Ying Li; Xiaoyan He; Yibo Zhang; Lin Lu; Weifeng Shen; Qi Zhang; Ke Yang
Journal:  J Am Heart Assoc       Date:  2019-09-28       Impact factor: 5.501

Review 10.  Leptin in Atherosclerosis: Focus on Macrophages, Endothelial and Smooth Muscle Cells.

Authors:  Priya Raman; Saugat Khanal
Journal:  Int J Mol Sci       Date:  2021-05-21       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.